Complete Genomics' Q2 Revenues Rise 47 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Complete Genomics reported after the close of the market on Wednesday a 47 percent increase in revenues year over year for the second quarter, beating the average analyst estimate on the top and bottom line.

The Mountain View, Calif.-based sequencing services company recorded $8.7 million in revenues for the three months ended June 30, up from $5.9 million a year ago, topping the consensus Wall Street estimate of $7.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.